Genscript Biotech Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Genscript Biotech stock has a consensus rating of "Strong Buy" and an average price target of $17.68. The average 1-year stock price forecast is 29.24% higher than the current stock price, while the lowest is $15.50 (+13.30%) and the highest is $21.03 (+53.73%).

Price Target: $17.68 (+29.24%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15.50	$17.68	$17.16	$21.03
Change	+13.30%	+29.24%	+25.44%	+53.73%

Analyst Ratings

The average analyst rating for Genscript Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	8	8	8	8	6	6
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Guotai Haitong No rating	Guotai Haitong	Buy Maintains $25.57	Buy	Maintains	$25.57	+86.92%	May 14, 2026
Cui Cui Jefferies	Jefferies	Buy Maintains $15.50	Buy	Maintains	$15.50	+13.30%	Apr 3, 2026
Unknown Analyst J.P. Morgan No rating	J.P. Morgan	Buy Maintains $24.00 → $20.00	Buy	Maintains	$24.00 → $20.00	+46.20%	Mar 19, 2026
Unknown Analyst CICC No rating	CICC	Buy Maintains $17.90	Buy	Maintains	$17.90	+30.85%	Mar 19, 2026
Unknown Analyst Huatai Securities No rating	Huatai Securities	Buy Maintains $16.26	Buy	Maintains	$16.26	+18.86%	Mar 18, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.